Viewing Study NCT02171533


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-07 @ 12:59 PM
Study NCT ID: NCT02171533
Status: COMPLETED
Last Update Posted: 2014-06-24
First Post: 2014-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module